{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:39:27Z","timestamp":1792579167676,"version":"4.5.0"},"reference-count":37,"publisher":"Journal of Biomedical Research","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2026]]},"DOI":"10.7555\/jbr.39.20250475","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:53:31Z","timestamp":1777355611000},"page":"1","source":"Crossref","is-referenced-by-count":0,"title":["Progressive IL-13 signaling promotes inflammation-associated liver fibrosis &lt;i&gt;via&lt;\/i&gt; IL-13RA2\/MEK\/ERK activation in &lt;i&gt;Schistosoma japonicum&lt;\/i&gt; infection"],"prefix":"10.7555","volume":"40","author":[{"given":"Ruiyan","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyue","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4380","reference":[{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.1","doi-asserted-by":"publisher","unstructured":"Kokaliaris C, Garba A, Matuska M, et al. Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: A spatiotemporal modelling study[J]. <i>Lancet Infect Dis<\/i>, 2022, 22(1): 136\u2013149.","DOI":"10.1016\/S1473-3099(21)00090-6"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.2","doi-asserted-by":"publisher","unstructured":"Huang J, Yin X, Zhang L, et al. Serum proteomic profiling in patients with advanced <i>Schistosoma japonicum<\/i>-induced hepatic fibrosis[J]. <i>Parasites Vectors<\/i>, 2021, 14(1): 232.","DOI":"10.1186\/s13071-021-04734-1"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.3","doi-asserted-by":"publisher","unstructured":"McManus DP, Dunne DW, Sacko M, et al. Schistosomiasis[J]. <i>Nat Rev Dis Primers<\/i>, 2018, 4(1): 13.","DOI":"10.1038\/s41572-018-0013-8"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.4","doi-asserted-by":"publisher","unstructured":"Zhang Y, Li J, Li H, et al. A preliminary investigation into the immune cell landscape of schistosome-associated liver fibrosis in humans[J]. <i>Immunol Cell Biol<\/i>, 2021, 99(8): 803\u2013813.","DOI":"10.1111\/imcb.12490"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.5","doi-asserted-by":"publisher","unstructured":"Ding T, Ge S. Metabolic regulation of type 2 immune response during tissue repair and regeneration[J]. <i>J Leukoc Biol<\/i>, 2022, 112(5): 1013\u20131023.","DOI":"10.1002\/JLB.3MR0422-665R"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.6","doi-asserted-by":"publisher","unstructured":"Abdel Aziz N, Musaigwa F, Mosala P, et al. Type 2 immunity: A two-edged sword in schistosomiasis immunopathology[J]. <i>Trends Immunol<\/i>, 2022, 43(8): 657\u2013673.","DOI":"10.1016\/j.it.2022.06.005"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.7","doi-asserted-by":"publisher","unstructured":"Song LJ, Yin XR, Mu SS, et al. The differential and dynamic progression of hepatic inflammation and immune responses during liver fibrosis induced by <i>Schistosoma japonicum<\/i> or carbon tetrachloride in mice[J]. <i>Front Immunol<\/i>, 2020, 11: 570524.","DOI":"10.3389\/fimmu.2020.570524"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.8","doi-asserted-by":"publisher","unstructured":"Wang Z, Du K, Jin N, et al. Macrophage in liver Fibrosis: Identities and mechanisms[J]. <i>Int Immunopharmacol<\/i>, 2023, 120: 110357.","DOI":"10.1016\/j.intimp.2023.110357"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.9","doi-asserted-by":"publisher","unstructured":"Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis[J]. <i>Nat Rev Gastroenterol Hepatol<\/i>, 2023, 20(10): 633\u2013646.","DOI":"10.1038\/s41575-023-00807-x"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.10","unstructured":"Rahaman SO, Sharma P, Harbor PC, et al. IL-13R\u03b12, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells[J]. <i>Cancer Res<\/i>, 2002, 62(4): 1103\u20131109."},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.11","doi-asserted-by":"publisher","unstructured":"Daines MO, Hershey GKK. A novel mechanism by which interferon-\u03b3 can regulate interleukin (IL)-13 responses: Evidence for intracellular stores of IL-13 receptor \u03b1-2 and their rapid mobilization by interferon-\u03b3[J]. <i>J Biol Chem<\/i>, 2002, 277(12): 10387\u201310393.","DOI":"10.1074\/jbc.M108109200"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.12","doi-asserted-by":"publisher","unstructured":"Zhao X, Yang W, Yu T, et al. Th17 cell-derived amphiregulin promotes colitis-associated intestinal fibrosis through activation of mTOR and MEK in intestinal myofibroblasts[J]. <i>Gastroenterology<\/i>, 2023, 164(1): 89\u2013102.","DOI":"10.1053\/j.gastro.2022.09.006"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.13","doi-asserted-by":"publisher","unstructured":"Lumsden RV, Worrell JC, Boylan D, et al. Modulation of pulmonary fibrosis by IL-13R\u03b12[J]. <i>Am J Physiol Lung Cell Mol Physiol<\/i>, 2015, 308(7): L710\u2013L718.","DOI":"10.1152\/ajplung.00120.2014"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.14","doi-asserted-by":"publisher","unstructured":"Ullah R, Yin Q, Snell AH, et al. RAF-MEK-ERK pathway in cancer evolution and treatment[J]. <i>Semin Cancer Biol<\/i>, 2022, 85: 123\u2013154.","DOI":"10.1016\/j.semcancer.2021.05.010"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.15","doi-asserted-by":"publisher","unstructured":"Wang X, Lu Y, Wu L, et al. Moxibustion inhibits the ERK signaling pathway and intestinal fibrosis in rats with Crohn's disease[J]. <i>Evid Based Complement Alternat Med<\/i>, 2013, 2013(1): 198282.","DOI":"10.1155\/2013\/198282"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.16","doi-asserted-by":"publisher","unstructured":"Han C, Wu X, Zou N, et al. <i>Cichorium pumilum<\/i> Jacq extract inhibits LPS-induced inflammation <i>via<\/i> MAPK signaling pathway and protects rats from hepatic fibrosis caused by abnormalities in the gut-liver axis[J]. <i>Front Pharmacol<\/i>, 2021, 12: 683613.","DOI":"10.3389\/fphar.2021.683613"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.17","doi-asserted-by":"publisher","unstructured":"Chen H, Chen H, Liang J, et al. TGF-\u03b21\/IL-11\/MEK\/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of <i>Bmi-1<\/i> deficiency[J]. <i>Exp Mol Med<\/i>, 2020, 52(1): 130\u2013151.","DOI":"10.1038\/s12276-019-0371-7"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.18","doi-asserted-by":"publisher","unstructured":"Umbarkar P, Tousif S, Singh AP, et al. Fibroblast GSK-3\u03b1 promotes fibrosis <i>via<\/i> RAF-MEK-ERK pathway in the injured heart[J]. <i>Circ Res<\/i>, 2022, 131(7): 620\u2013636.","DOI":"10.1161\/CIRCRESAHA.122.321431"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.19","doi-asserted-by":"publisher","unstructured":"Mawa PA, Kincaid-Smith J, Tukahebwa EM, et al. Schistosomiasis morbidity hotspots: Roles of the human host, the parasite and their interface in the development of severe morbidity[J]. <i>Front Immunol<\/i>, 2021, 12: 635869.","DOI":"10.3389\/fimmu.2021.635869"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.20","doi-asserted-by":"publisher","unstructured":"Buonfrate D, Ferrari TCA, Adegnika AA, et al. Human schistosomiasis[J]. <i>Lancet<\/i>, 2025, 405(10479): 658\u2013670.","DOI":"10.1016\/S0140-6736(24)02814-9"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.21","doi-asserted-by":"publisher","unstructured":"Gieseck III RL, Wilson MS, Wynn TA. Type 2 immunity in tissue repair and fibrosis[J]. <i>Nat Rev Immunol<\/i>, 2018, 18(1): 62\u201376.","DOI":"10.1038\/nri.2017.90"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.22","doi-asserted-by":"publisher","unstructured":"Allen JE. IL-4 and IL-13: Regulators and effectors of wound repair[J]. <i>Annu Rev Immunol<\/i>, 2023, 41(1): 229\u2013254.","DOI":"10.1146\/annurev-immunol-101921-041206"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.23","doi-asserted-by":"publisher","unstructured":"Beschin A, De Baetselier P, Van Ginderachter JA. Contribution of myeloid cell subsets to liver fibrosis in parasite infection[J]. <i>J Pathol<\/i>, 2013, 229(2): 186\u2013197.","DOI":"10.1002\/path.4112"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.24","doi-asserted-by":"publisher","unstructured":"Rei\u00dfing J, Berres M, Strnad P, et al. Th2 cell activation in chronic liver disease is driven by local IL33 and contributes to IL13-dependent fibrogenesis[J]. <i>Cell Mol Gastroenterol Hepatol<\/i>, 2024, 17(4): 517\u2013538.","DOI":"10.1016\/j.jcmgh.2023.12.011"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.25","doi-asserted-by":"publisher","unstructured":"Fallon PG, Richardson EJ, McKenzie GJ, et al. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent[J]. <i>J Immunol<\/i>, 2000, 164(5): 2585\u20132591.","DOI":"10.4049\/jimmunol.164.5.2585"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.26","doi-asserted-by":"publisher","unstructured":"Vicentino ARR, Carneiro VC, Allonso D, et al. Emerging role of HMGB1 in the pathogenesis of schistosomiasis liver fibrosis[J]. <i>Front Immunol<\/i>, 2018, 9: 1979.","DOI":"10.3389\/fimmu.2018.01979"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.27","doi-asserted-by":"publisher","unstructured":"Yombo DJK, Odayar V, Gupta N, et al. The protective effects of IL-31RA deficiency during bleomycin-induced pulmonary fibrosis[J]. <i>Front Immunol<\/i>, 2021, 12: 645717.","DOI":"10.3389\/fimmu.2021.645717"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.28","doi-asserted-by":"publisher","unstructured":"Melo-Cardenas J, Bezavada L, Crawford JC, et al. IL-13\/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms[J]. <i>Blood<\/i>, 2022, 140(26): 2805\u20132817.","DOI":"10.1182\/blood.2022017326"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.29","doi-asserted-by":"publisher","unstructured":"Junttila IS. Tuning the cytokine responses: An update on interleukin (IL)-4 and IL-13 receptor complexes[J]. <i>Front Immunol<\/i>, 2018, 9: 888.","DOI":"10.3389\/fimmu.2018.00888"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.30","doi-asserted-by":"publisher","unstructured":"Vannella KM, Barron L, Borthwick LA, et al. Incomplete deletion of IL-4R\u03b1 by LysM<sup>Cre<\/sup> reveals distinct subsets of M2 macrophages controlling inflammation and fibrosis in chronic schistosomiasis[J]. <i>PLoS Pathog<\/i>, 2014, 10(9): e1004372.","DOI":"10.1371\/journal.ppat.1004372"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.31","doi-asserted-by":"publisher","unstructured":"Weng SY, Wang X, Vijayan S, et al. IL-4 receptor alpha signaling through macrophages differentially regulates liver fibrosis progression and reversal[J]. <i>EBioMedicine<\/i>, 2018, 29: 92\u2013103.","DOI":"10.1016\/j.ebiom.2018.01.028"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.32","doi-asserted-by":"publisher","unstructured":"Adhyatmika A, Putri KSS, Gore E, et al. Osteoprotegerin expression in liver is induced by IL13 through TGF\u03b2[J]. <i>Cell Physiol Biochem<\/i>, 2022, 56(1): 28\u201338.","DOI":"10.33594\/000000492"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.33","doi-asserted-by":"publisher","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-\u03b2: The master regulator of fibrosis[J]. <i>Nat Rev Nephrol<\/i>, 2016, 12(6): 325\u2013338.","DOI":"10.1038\/nrneph.2016.48"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.34","doi-asserted-by":"publisher","unstructured":"Liu J, Kong D, Qiu J, et al. Praziquantel ameliorates CCl<sub>4<\/sub>-induced liver fibrosis in mice by inhibiting TGF-\u03b2\/Smad signalling via up-regulating Smad7 in hepatic stellate cells[J]. <i>Br J Pharmacol<\/i>, 2019, 176(24): 4666\u20134680.","DOI":"10.1111\/bph.14831"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.35","doi-asserted-by":"publisher","unstructured":"Fichtner-Feigl S, Young CA, Kitani A, et al. IL-13 signaling via IL-13R\u03b1<sub>2<\/sub> induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis[J]. <i>Gastroenterology<\/i>, 2008, 135(6): 2003\u20132013.e20137.","DOI":"10.1053\/j.gastro.2008.08.055"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.36","doi-asserted-by":"publisher","unstructured":"He CH, Lee CG, Dela Cruz CS, et al. Chitinase 3-like 1 regulates cellular and tissue responses <i>via<\/i> IL-13 receptor \u03b12[J]. <i>Cell Rep<\/i>, 2013, 4(4): 830\u2013841.","DOI":"10.1016\/j.celrep.2013.07.032"},{"key":"10.7555\/JBR.39.20250475.swyxyjzzywb.37","doi-asserted-by":"publisher","unstructured":"Mentink-Kane MM, Wynn TA. Opposing roles for IL-13 and IL-13 receptor \u03b12 in health and disease[J]. <i>Immunol Rev<\/i>, 2004, 202(1): 191\u2013202.","DOI":"10.1111\/j.0105-2896.2004.00210.x"}],"container-title":["Journal of Biomedical Research"],"original-title":[],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:54:43Z","timestamp":1792576483000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.39.20250475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":37,"alternative-id":["JBR-2025-0475"],"URL":"https:\/\/doi.org\/10.7555\/jbr.39.20250475","relation":{},"ISSN":["1674-8301","1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"},{"value":"1674-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}